Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raber

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Urology|January 1, 1996
Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancerM Maffezzini, A Simonato, M Zanon, et al.
Tumori|May 1, 1995
Short schedule intravesical mitomycin preceding transurethral resection for recurrent Ta-T1, G1-G2 bladder cancerM Maffezzini, A Simonato, C Lodolo, et al.
Ophthalmic Surgery and Lasers|January 15, 1998
A simple method for accurate centering of the Hessburg-Barron suction trephine during penetrating keratoplastyP D Van Rensburg, I M Raber, S E Orlin
Schmerz (Berlin, Germany)|December 1, 1994
[Drug therapy for tumor pain I. Properties of non-opioids and opioids.]N I Cherny, R K Portenoy, M Raber, et al.
International Journal of Oncology|May 11, 2011
Phase-I and phase-ii trials of a laboratory-derived synergistic combination of Cisplatin and 2'-deoxy-5-azacytidineR Lenzi, M Raber, D Gravel, et al.
Schmerz (Berlin, Germany)|January 1, 1995
[Pharmacotherapy of cancer pain : 2. Use of opioids.]N I Cherny, R K Portenoy, M Raber, et al.
Arzneimittel-Forschung|August 12, 1999
Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditionsM Raber, H U Schulz, M Schürer, et al.
Arzneimittel-Forschung|August 12, 1999
Pharmacokinetic properties of tramadol sustained release capsules. 1st communication: investigation of dose linearityH U Schulz, M Raber, M Schürer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase I trial of a 72-h continuous-infusion schedule of fazarabineR Amato, D Ho, S Schmidt, et al.
Cornea|August 30, 2008
Histopathology of posterior lamellar endothelial keratoplasty graft failureJames A Sbarbaro, Ralph C Eagle, Prathima Thumma, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Urology|January 1, 1996
Up-front intravesical chemotherapy for low stage, low grade recurrent bladder cancerM Maffezzini, A Simonato, M Zanon, et al.
Tumori|May 1, 1995
Short schedule intravesical mitomycin preceding transurethral resection for recurrent Ta-T1, G1-G2 bladder cancerM Maffezzini, A Simonato, C Lodolo, et al.
Ophthalmic Surgery and Lasers|January 15, 1998
A simple method for accurate centering of the Hessburg-Barron suction trephine during penetrating keratoplastyP D Van Rensburg, I M Raber, S E Orlin
Schmerz (Berlin, Germany)|December 1, 1994
[Drug therapy for tumor pain I. Properties of non-opioids and opioids.]N I Cherny, R K Portenoy, M Raber, et al.
International Journal of Oncology|May 11, 2011
Phase-I and phase-ii trials of a laboratory-derived synergistic combination of Cisplatin and 2'-deoxy-5-azacytidineR Lenzi, M Raber, D Gravel, et al.
Schmerz (Berlin, Germany)|January 1, 1995
[Pharmacotherapy of cancer pain : 2. Use of opioids.]N I Cherny, R K Portenoy, M Raber, et al.
Arzneimittel-Forschung|August 12, 1999
Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditionsM Raber, H U Schulz, M Schürer, et al.
Arzneimittel-Forschung|August 12, 1999
Pharmacokinetic properties of tramadol sustained release capsules. 1st communication: investigation of dose linearityH U Schulz, M Raber, M Schürer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase I trial of a 72-h continuous-infusion schedule of fazarabineR Amato, D Ho, S Schmidt, et al.
Cornea|August 30, 2008
Histopathology of posterior lamellar endothelial keratoplasty graft failureJames A Sbarbaro, Ralph C Eagle, Prathima Thumma, et al.
Pageof 11